Post vaginal hysterectomy serotonin syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20243609Keywords:
Methylene blue, Serotonin syndrome, Vaginal hysterectomyAbstract
Serotonin syndrome is a potentially fatal complication associated with the use of methylene blue dye and antidepressants. Methylene blue is a dye commonly used to visualize structures in OB/GYN surgeries. Due to difficulty in manufacturing other dyes, more physicians will likely have to use methylene blue, thus making the knowledge of its monoamine oxidase inhibition properties even more vital in the prevention of serotonin syndrome complications. Serotonin syndrome is a potentially deadly disease that has a high likelihood of occurring if methylene blue is used concurrently with any type of serotonin modulating agent. While it is listed as a black box warning when used with anti-depressants, it is still relatively rare but should be considered in cases such as these.
Metrics
References
Diaz G. Serotonin Syndrome Drug Precipitants and Pharmacology. 2012. Available at: https://www.grepmed.com. Accessed on 12 July 2014.
Drug shortage detail: Indigo carmine injection. ASHP. 2018. Available at: https://www.ashp.org. Accessed on 15 July 2024.
Gillman PK. CNS toxicity involving methylene blue: The exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. Journal of Psychopharmacol. 2010;25(3):429-36.
Pedavally S, Fugate JE, Rabinstein AA. Serotonin syndrome in the intensive care unit: Clinical Presentations and precipitating medications. Neurocritical Care. 2013;21(1):108–13.
Locke, A. Methylene blue and the risk of serotonin toxicity. Anesthesia Patient Safety Foundation. 2012. Available at: https://www.apsf.org/article/methylene-blue-and-the-risk-of-serotonin-toxicity. Accessed on 30 July 2024.
Ng BK, Cameron AJ, Liang R, Rahman H. Serotonin syndrome following methylene blue infusion during parathyroidectomy: A case report and literature review. Canadian J Anesthesia Canadien d’anesthésie. 2008;55(1):36–41.
